Mouth Ulcer Statistics 2026

Mouth Ulcer Stats

Global Prevalence, Market Data & Clinical Research Insights

AT A GLANCE

• 25% — Of global population affected by recurrent aphthous (canker sore) ulcers
• $1.45B — Global mouth ulcer treatment market value in 2026
• $2.28B — Projected treatment market size by 2032 at 7.55% CAGR
• 4% — Estimated worldwide point prevalence of active oral ulcers
• 20% — Of the population experiences mouth ulcers at some point in their lives
• 21% — North America’s share of the global mouth ulcer treatment market in 2025
• 15%–30% — Global population affected by recurrent mouth ulcers per British Dental Journal
• >70% — Of recurrent aphthous stomatitis cases are the minor ulcer subtype
• 2% — Estimated genetic heritability of mouth ulcer susceptibility

25% of Global Population — Aphthous Ulcers Are Among the World’s Most Common Oral Conditions

The scale of mouth ulcer prevalence is staggering. According to IMARC Group’s Mouth Ulcer Treatment Market analysis, approximately 25% of the global population is affected by recurrent aphthous stomatitis (RAS) — the most common form of mouth ulcer, also known as canker sores. This figure, corroborated by an article published in the National Library of Medicine, places RAS among the most widespread non-contagious oral conditions on earth. The condition is driven by a complex mix of genetics, nutritional deficiencies, immune dysfunction, and stress, and its recurrent nature means that for many sufferers, mouth ulcers are a chronic, lifelong experience rather than a one-time event. A quarter of the world’s population experiencing this condition creates not only a massive quality-of-life burden but also sustains a multi-billion-dollar global treatment market, as patients continually seek faster, safer, and more effective relief options.

$1.45 Billion in 2026 — Treatment Market Grows Steadily Amid Rising Demand

The global mouth ulcer treatment market reached $1.45 billion in 2026, growing from $1.37 billion in 2025, according to Research and Markets. With a projected CAGR of 7.55%, the market is expected to reach $2.28 billion by 2032. This expansion is driven by consumer demand for rapid and convenient relief, growing clinical focus on efficacy and safety in therapeutic oral care, and the integration of new delivery technologies including mucoadhesive patches, sustained-release formulations, and combination drug platforms. Distribution is diversifying across hospital pharmacies, retail channels, and rapidly growing online pharmacies — a shift that is broadening product accessibility to underserved populations worldwide and accelerating overall market penetration. For manufacturers, the 2026 milestone signals that mouth ulcer care has graduated from a minor OTC category to a mainstream oral healthcare investment priority.

$2.09 Billion by 2031 — Aphthous Stomatitis Drives 63.78% of Market Share

Among the various types of mouth ulcers, aphthous stomatitis alone accounted for a 63.78% share of the mouth ulcer treatment market in 2025, according to Mordor Intelligence’s Mouth Ulcer Treatment Market Report. The market was valued at $1.75 billion in 2026 and is projected to grow to $2.09 billion by 2031 at a CAGR of 3.61%. North America captured 38.21% of 2025 sales, while Asia-Pacific is advancing at the fastest regional pace of 5.44% CAGR. Meanwhile, analgesics retained 38.22% of the treatment market in 2025, though anesthetics are gaining ground at a 4.03% CAGR as patients increasingly prefer fast-acting numbing agents that allow normal daily function. This data highlights the pivotal role that aphthous ulcers play in shaping the entire treatment landscape — and why pharmaceutical innovation in this specific indication is so commercially significant.

4% Global Point Prevalence — Millions Actively Suffering at Any Given Moment

The estimated point prevalence of oral ulcers worldwide — meaning the percentage of people actively experiencing a mouth ulcer at any given time — stands at approximately 4%, as cited by Fairfield Market Research. With the global population exceeding 8 billion, a 4% point prevalence translates to over 320 million people experiencing an active mouth ulcer at any moment. The same research also confirms that self-reported prevalence of oral ulcers varies widely from 0% to 35% depending on diagnostic criteria and populations studied. The global mouth ulcers treatment market associated with this burden was projected to reach $2,047.9 million by 2026. North America leads regional market value at an estimated $603.5 million, reflecting both the high awareness of oral health in the region and the concentration of leading pharmaceutical manufacturers investing in advanced treatment formulations.

20% of Population Affected Over a Lifetime — Adults Bear the Greatest Burden

Beyond point prevalence, lifetime exposure to mouth ulcers is considerably broader. According to Market Research Future, approximately 20% of the population experiences mouth ulcers at some point in their lives. Adults represent the dominant patient demographic — accounting for the largest market share — as stress, dietary choices, and underlying chronic health conditions create a steady and recurring demand for treatment. The mouth ulcer treatment industry is projected to grow from $4.33 billion in 2025 to $5.63 billion by 2035 at a CAGR of 2.65%, reflecting the durable, long-term nature of demand. Children represent an emerging segment, with rising diagnostic rates and parental demand driving growth in pediatric-specific formulations. This lifetime prevalence figure reinforces why mouth ulcer treatment is not a niche category — it is a universal health experience that touches people across every age group and demographic.

15%–30% Global Recurrence Rate — Half of All Age Groups Affected at Some Frequency

British Dental Journal estimates, referenced in Coherent Market Insights’ Mouth Ulcer Treatment Market analysis, indicate that recurrent mouth ulcers affect 15% to 30% of the global population, with a frequency rate touching 50% of people across all age groups at some point. This recurrence data is clinically significant: unlike a one-time injury or infection, recurrent aphthous stomatitis has no permanent cure, meaning patients cycle through treatment products repeatedly throughout their lives. This chronic recurrence pattern is a primary driver of sustained market demand for analgesic gels, antiseptic mouthwashes, lozenges, and corticosteroid sprays. Common contributing causes include tissue injury, citric and acidic foods, genetic predisposition, food allergies, nutritional deficiencies, and impaired immunity. The treatment market is expected to reach $2.3 billion by 2033, powered largely by this repeating consumer base.

>70% Minor Subtype — NCBI Research Defines the Clinical Landscape

Clinical classification data from StatPearls via NCBI — Recurrent Aphthous Stomatitis confirms that of the three subtypes of recurrent aphthous stomatitis, minor aphthous ulcers account for more than 70% of all cases, while major and herpetiform subtypes each account for approximately 10%. Minor ulcers are characterized by small sores of 2–4mm in diameter, resolve within 7–10 days without scarring, and recur every 1–4 months. This subtype dominance explains why OTC treatments — rather than prescription-only therapies — account for the majority of market revenue. Straits Research further confirms that the global prevalence of aphthous ulcers affecting 25% of the world’s population, combined with Asia-Pacific’s rapidly growing patient base (driven by spicy food consumption, tobacco use, and an expanding middle class), positions the region as the fastest-growing treatment market globally, with consistent double-digit growth in treatment accessibility and consumer spending on oral care.

8.2% Genetic Heritability — Genome-Wide Study Identifies 97 Linked Loci

One of the most groundbreaking insights into mouth ulcer science comes from genetic research published in Nature Communications — Genome-Wide Analysis for Mouth Ulcers. The landmark genome-wide association study (GWAS) conducted in the UK Biobank estimated the heritability of mouth ulcer susceptibility at 8.2% under an infinitesimal model, rising to 8.7% under a non-infinitesimal model. Researchers identified 97 genetic loci associated with mouth ulcer development — with the strongest single-variant association found near HLA-B on chromosome 6, highlighting the role of T-cell mediated immunity in ulcer formation. These findings confirm what clinical practice has long suggested: that for a meaningful segment of mouth ulcer sufferers, the condition is not simply a lifestyle or dietary problem, but a genetically predisposed immune response — one that will not be fully resolved by behavioral changes alone and may require targeted immunomodulatory treatment approaches in the future.

$2.3 Billion by 2033 — Corticosteroids Lead, Natural Remedies Surge

The global mouth ulcer drugs market is projected to reach $2.3 billion by 2033, growing at a CAGR of 2.9%, according to iHealthcare Analyst. Corticosteroids currently command the largest drug class share, serving as the first-line treatment for immune-mediated ulcers and offering faster lesion resolution and pain relief. Meanwhile, a significant market trend is the surge in demand for natural and herbal treatment alternatives, as consumers seek formulations with fewer systemic side effects than steroid-based therapies. The peer-reviewed PMC review — Revisited and Innovative Perspectives of Oral Ulcer Treatment notes that recurrent aphthous ulcers (RAU) affect approximately 25% of young adults, with the highest concentration in the 10–30 age group. The combination of a large, young patient population, a growing preference for botanical actives and mucoadhesive delivery systems, and expanding e-commerce access to OTC treatments ensures that market growth will remain robust well into the next decade.

FREQUENTLY ASKED QUESTIONS

What causes mouth ulcers?

Mouth ulcers are caused by a wide range of factors. The two most common causes are local physical trauma (such as accidentally biting the inside of your cheek, irritation from braces, or a sharp tooth edge) and recurrent aphthous stomatitis (canker sores), a condition with no fully understood cause but linked to genetic predisposition, stress, nutritional deficiencies (particularly B12, folate, and iron), hormonal changes, food sensitivities, and immune system dysfunction. Other causes include viral infections (such as herpes simplex), certain medications, autoimmune diseases like Behçet’s disease, inflammatory bowel conditions such as Crohn’s disease, and side effects of chemotherapy.

How to cure mouth ulcers fast naturally

Several natural approaches can accelerate mouth ulcer healing: (1) Salt water rinses — dissolve 1 teaspoon of salt in a cup of warm water and rinse 3–4 times daily to reduce inflammation and bacteria; (2) Honey — apply raw honey directly to the ulcer, as it has well-documented antimicrobial and wound-healing properties; (3) Coconut oil — its lauric acid has antimicrobial effects and can be dabbed onto the sore; (4) Aloe vera gel — apply directly to reduce pain and inflammation; (5) Turmeric paste — mixed with water and applied topically, it has anti-inflammatory and antiseptic properties; (6) Chamomile tea rinse — used as a warm mouth rinse to soothe inflamed tissue. Avoiding acidic, spicy, and salty foods during healing is also essential.

What antiseptic gel can you use for mouth ulcers?

Several antiseptic gels are widely used and clinically supported for mouth ulcer treatment. Benzydamine hydrochloride (Difflam) gel and spray are among the most recommended, offering both antiseptic and anti-inflammatory action. Chlorhexidine gluconate gels (e.g., Corsodyl gel) help prevent secondary infection and can reduce ulcer duration. Lidocaine-based topical gels (such as Orajel) provide immediate numbing pain relief. Choline salicylate gel (Bonjela) is another popular OTC option that offers both analgesic and antiseptic effects. For more severe or persistent ulcers, corticosteroid gels such as triamcinolone acetonide in dental paste (Kenalog in Orabase) may be prescribed by a dentist or physician.

How to treat mouth ulcers

Treatment depends on ulcer severity and frequency. For minor ulcers: use topical analgesic gels (lidocaine, choline salicylate), antiseptic mouthwashes (chlorhexidine), and avoid irritating foods. Salt water or bicarbonate of soda rinses can relieve discomfort. Over-the-counter protective pastes (Orabase) create a physical barrier over the ulcer. For more persistent or painful ulcers, a doctor may prescribe corticosteroid mouthwash, tablets (hydrocortisone buccal), or triamcinolone paste. In cases of recurrent aphthous stomatitis, blood tests to check for nutritional deficiencies (iron, B12, folate) are recommended, as supplementation can significantly reduce recurrence in deficient patients.

How to get rid of ulcer in mouth

Most mouth ulcers heal on their own within 7–14 days without treatment. To speed healing and reduce discomfort: apply a topical anaesthetic gel (such as benzocaine or lidocaine) directly to the ulcer; rinse with an antiseptic mouthwash containing chlorhexidine; avoid touching or biting the ulcer; stay well-hydrated and eat a soft, non-acidic diet; take over-the-counter pain relievers (ibuprofen or paracetamol) if pain is significant. If an ulcer does not heal within 3 weeks, grows rapidly, or you develop multiple large ulcers, consult a doctor or dentist promptly to rule out more serious underlying conditions.

What is a mouth ulcer?

A mouth ulcer (also called an aphtha or canker sore) is an open sore that develops on the mucous membrane lining of the mouth — including the inner cheeks, lips, tongue, gums, floor, and roof of the mouth. They typically appear as small, round or oval lesions with a white or yellow center and a red, inflamed border. Most mouth ulcers are benign, non-contagious, and heal without scarring within 1–2 weeks. They range from minor (under 1cm, most common) to major (over 1cm, slower to heal) and herpetiform (clusters of very small ulcers). While not usually dangerous, a mouth ulcer that does not heal within 3 weeks should be evaluated by a healthcare provider to rule out oral cancer.

What is the fastest way to cure mouth ulcers?

Clinically, the fastest healing is achieved through a combination approach: (1) Apply a corticosteroid gel or paste (such as triamcinolone acetonide) as soon as the ulcer appears — this is the most evidence-backed approach for reducing duration and severity; (2) Use a topical anesthetic (lidocaine gel or spray) for immediate pain relief; (3) Rinse with chlorhexidine mouthwash twice daily to prevent secondary infection; (4) Take a B12 supplement if deficiency is suspected — clinical trials have shown B12 supplementation can significantly reduce ulcer frequency and duration. Many patients find that acting at the very first tingle of an incoming ulcer, before it fully forms, dramatically reduces its size and healing time.

How to heal mouth ulcers

To effectively heal mouth ulcers: keep the area clean with salt water or antiseptic rinses; apply a mucoadhesive protective paste (such as Orabase) to shield the ulcer from food and saliva irritation; use a topical corticosteroid or analgesic gel to reduce inflammation and pain; avoid spicy, acidic, and hard foods that worsen irritation; stay hydrated and eat soft foods such as yogurt, mashed potatoes, and smoothies; do not use SLS-containing (sodium lauryl sulfate) toothpaste, as this ingredient has been linked to increased mouth ulcer frequency. For chronic recurring ulcers, consider discussing prophylactic low-dose colchicine, dapsone, or immunomodulatory therapy with a specialist, particularly if ulcers are large, frequent, or linked to an underlying autoimmune condition.

Sources: Research and Markets • Fairfield Market Research • Mordor Intelligence • Nature Communications • Data Insights Market • Straits Research • Wikipedia • Polaris Market Research • Market Research Future • Coherent Market Insights • NCBI StatPearls • iHealthcare Analyst • PMC | Data compiled May 2026